https://www.selleckchem.com/pr....oducts/namodenoson-c
24) and 0.93 (95% CrI 0.78-1.14), respectively, as compared to RFA. For LR at 3 years, CA and MWA had RR of 0.96 (0.74-1.23) and 0.98 (0.87-1.09), respectively, as compared to RFA. Overall, none of the comparisons was statistically significant. Age of patients and tumor size did not influence treatment effect. RFA, MWA, and CA are equally effective for locoregional treatment of very early and early HCC. • There is no significant difference in the OS and LR (at 1 year and 3 years) following ablation of very early and early HCC
Like
Comment
Share
